These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4266261)

  • 21. Purification and regulatory properties of ATP-sensitive phosphofructokinase from yeast.
    Atzpodien W; Bode H
    Eur J Biochem; 1970 Jan; 12(1):126-32. PubMed ID: 4244795
    [No Abstract]   [Full Text] [Related]  

  • 22. Physical and kinetic properties of human phosphofructokinase from skeletal muscle and erythrocytes.
    Layzer RB; Rowland LP; Bank WJ
    J Biol Chem; 1969 Jul; 244(14):3823-31. PubMed ID: 4241008
    [No Abstract]   [Full Text] [Related]  

  • 23. On the association of glycolytic components in skeletal muscle extracts.
    Clarke FM; Masters CJ
    Biochim Biophys Acta; 1974 Jul; 358(1):193-207. PubMed ID: 4277592
    [No Abstract]   [Full Text] [Related]  

  • 24. Purification of phosphofructokinase from rabbit skeletal muscle based on its ability to aggregate in absence of its effectors.
    Pandian S; Bhatia M; Ramaiah A; Hanspal JS
    Anal Biochem; 1983 Feb; 128(2):363-70. PubMed ID: 6221673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The self-association of rabbit-muscle phosphofructokinase.
    Leonard KR; Walker IO
    Eur J Biochem; 1972 Apr; 26(3):442-8. PubMed ID: 4260953
    [No Abstract]   [Full Text] [Related]  

  • 26. pH-induced cold lability of rabbit skeletal muscle phosphofructokinase.
    Bock PE; Frieden C
    Biochemistry; 1974 Sep; 13(20):4191-6. PubMed ID: 4277765
    [No Abstract]   [Full Text] [Related]  

  • 27. Allosteric properties of muscle phosphofructokinase. I. Binding of magnesium adenosine triphosphate to the inhibitory site.
    Kemp RG
    Biochemistry; 1969 Aug; 8(8):3162-8. PubMed ID: 4241302
    [No Abstract]   [Full Text] [Related]  

  • 28. Phosphofructokinase: studies on the subunit structure.
    Paetkau VH; Younathan ES; Lardy HA
    J Mol Biol; 1968 May; 33(3):721-36. PubMed ID: 4236061
    [No Abstract]   [Full Text] [Related]  

  • 29. Phosphofructokinase.
    Mansour TE
    Curr Top Cell Regul; 1972; 5():1-46. PubMed ID: 4271851
    [No Abstract]   [Full Text] [Related]  

  • 30. Inactivation of phosphofructokinase by 6-mercapto-9- -D-ribofuranosylpurine 5'-triphosphate.
    Bloxham DP; Clark MG; Holland PC; Lardy HA
    Biochemistry; 1973 Apr; 12(8):1596-601. PubMed ID: 4267013
    [No Abstract]   [Full Text] [Related]  

  • 31. [Yeast phosphofructokinase: studies on substrate and pH-dependent inactivation and reactivation].
    Liebe S; Kopperschläger G; Diezel W; Hofmann E
    Acta Biol Med Ger; 1972; 28(3):423-9. PubMed ID: 4261897
    [No Abstract]   [Full Text] [Related]  

  • 32. Magnetic resonance and catalytic studies of pyruvate kinase with essential sulfhydryl or lysyl epsilon-amino groups chemically modified.
    Flashner M; Tamir I; Mildvan AS; Meloche HP; Coon MJ
    J Biol Chem; 1973 May; 248(10):3419-25. PubMed ID: 4702870
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetic properties of the phosphofructokinase from erythrocytes of rats and rabbits. 2. The influence of effectors under nearly cellular conditions.
    Kühn B; Jacobasch G; Gerth C; Rapoport SM
    Eur J Biochem; 1974 Apr; 43(3):443-50. PubMed ID: 4275501
    [No Abstract]   [Full Text] [Related]  

  • 34. A kinetic model for phosphofructokinase based on the paradoxical action of effectors.
    Kemp RG; Tsai MY; Colombo G
    Biochem Biophys Res Commun; 1976 Feb; 68(3):942-8. PubMed ID: 177015
    [No Abstract]   [Full Text] [Related]  

  • 35. Allosteric properties of muscle phosphofructokinase. II. Kinetics of native and thiol-modified enzyme.
    Kemp RG
    Biochemistry; 1969 Nov; 8(11):4490-6. PubMed ID: 4242847
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple inhibitor sites for ATP on muscle phosphofructokinase as influenced by a change of pH: a computer analysis of "non-linear" kinetic data.
    Ui M
    Biochim Biophys Acta; 1968 Apr; 159(1):50-63. PubMed ID: 4231305
    [No Abstract]   [Full Text] [Related]  

  • 37. [Properties of erythrocyte phosphofructokinase in normal humans].
    Mandereau J; Boivin P
    Biochimie; 1973; 55(11):1341-51. PubMed ID: 4364375
    [No Abstract]   [Full Text] [Related]  

  • 38. Phosphofructokinase. Correlation of physical and enzymatic properties.
    Paetkau V; Lardy HA
    J Biol Chem; 1967 May; 242(9):2035-42. PubMed ID: 4225717
    [No Abstract]   [Full Text] [Related]  

  • 39. Aggregation of rabbit muscle phosphofructokinase.
    Pavelich MJ; Hammes GG
    Biochemistry; 1973 Mar; 12(7):1408-14. PubMed ID: 4266756
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction of phosphofructokinase with the fluorescent probe-2-(N-methylanilino)naphthalene-6-sulphonate.
    Hofer HW; Radda GK
    Eur J Biochem; 1974 Mar; 42(2):341-7. PubMed ID: 4275249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.